Researchers



Results 1-20 of 95
Issue DateTitleAuthor(s)TypeМp-cat.
2026Generative machine learning and alchemical free-energy perturbation for the discovery of non-peptidic tau aggregation inhibitorsIlić, Budimir S.  Conference Paper
Mp. category will be shown later
2026Targeting FFAR3 with microbiota-derived propionate: a molecular dynamics perspective on Parkinson’s disease modulationIlić, Budimir S.  Conference Paper
Mp. category will be shown later
2026Epigallocatechin Gallate as a State-Dependent Modulator of Amyloid-β: Molecular Simulation-Guided Mechanistic Synthesis for Structure-Based Inhibitor DesignIlić, Budimir S.  Article
21M21
2026Microbiota-derived indole-3-propionic acid disrupts Aβ42 aggregation: molecular insights toward neuro-motor preservation in Alzheimer’s diseaseIlić, Budimir S.  Conference Paper
Mp. category will be shown later
2026Predicting BACE1 inhibitor residence time using machine learning and enhanced-sampling molecular dynamicsIlić, Budimir S.  Conference Paper
Mp. category will be shown later
2025Inhibitory Potential of Boscalid and Abamectin Towards Acetylcholinesterase and Butyrylcholinesterase: Computational and In Vitro StudiesArsić, Biljana  ; Petrović, Stefan  ; Ilić, Budimir S.  ; Vrecl, Milka; Trobec, Tomaž; Sepčić, Kristina; Frangež, Robert; Glišić, Sanja M.  ; Milićević, Jelena S.  Article
21M21
2025Machine Learning-Guided Rational Design of Coumarin-Based Organic Fluorophores for Photonic and Biomedical ApplicationsIlić, Budimir S.  Conference Paper
Mp. category will be shown later
2025From Existing Medicines to New Applications: Drug Repurposing Approach for Dengue FeverDenis Mitov; Ilić, Budimir S.  ; Arsić, BiljanaConference Paper
Mp. category will be shown later
2025Myricetin as a molecular brake: Dynamic simulation of its binding to the α-synuclein monomer in the context of Parkinson’s diseaseIlić, Budimir S.  Conference Paper
Mp. category will be shown later
2025Hit Selection of Dipeptidyl Peptidase-4 Inhibitors Bearing Thieno[2,3-d]Pyrimidine ScaffoldTomovic-Pavlovic, Katarina  ; Ilic, Budimir S  ; Dimov, Stefan; Yancheva, Denitsa; Mavrova, Anelia Ts; Smelcerovic, Andrija  Article
22M22
2025Phytochemical oleuropein aglycone targets N-terminal anchors of Aβ1–42: Molecular dynamics insights into early inhibition in Alzheimer’s diseaseIlić, Budimir S.  Conference Paper
Mp. category will be shown later
2025Drug Repurposing for Kala-AzarArsić, Biljana  ; Ilić, Budimir S.  ; Maier, Andreas; Hartung, Michael; Janjić, Jovana; Milićević, Jelena  ; Baumbach, JanArticle
21aM21a
2025PRAKTIKUM IZ ORGANSKE HEMIJEIlić, Budimir S.  Monograph
Mp. category will be shown later
2025Dengue drug discovery by repurposing approved drugsDenis Mitov; Milić, Nada; Ranđelović, Aleksandar; Ilić, Budimir S.  ; Milićević, Jelena; Arsić, BiljanaConference Paper
Mp. category will be shown later
2024Do machine learning and molecular dynamics reveal key insights into GABA-sulfonamide conjugates as carbonic anhydrase inhibitors?Ilić, Budimir S.  Article
53M53
2024Molecular dynamics of peptide-based inhibitor targeting Aβ42 fibril formation in Alzheimer'sIlić, Budimir S.  Conference Paper
Mp. category will be shown later
2024Molecular dynamics simulations of 7,8-dihydroxyflavone binding to TrkB receptor: Insights into agonistic mechanismIlić, Budimir S.  Conference Paper
Mp. category will be shown later
2024Disarming Parkinson’s: targeting key residues in alpha-synuclein with VAQKTmVIlić, Budimir S.  Conference Paper
Mp. category will be shown later
2024Molecular dynamics simulations of Ceftriaxone as drug candidate to prevent pathological alpha-synuclein aggregation in Parkinson's disease dementiaIlić, Budimir S.  Conference Paper
Mp. category will be shown later
2024Bis(benzimidazol-2-yl)amine-based DPP-4 Inhibitors Potentially Suitable for Combating Diabetes and Associated Nervous System Alterations.Pavlović, Katarina Tomović  ; Ilić, Budimir S  ; Leitzbach, Luisa; Anichina, Kameliya K; Yancheva, Denitsa; Živković, Aleksandra; Mavrova, Anelia Ts; Stark, Holger; Smelcerovic, Andrija  Article
22M22